Showing results (2241-2250 of 8,878) with videos related to
Sort By:
Pageof 888
BJU International|June 26, 2023
Low- versus standard- pneumoperitoneum in patients undergoing robot-assisted radical prostatectomy: a randomised, triple-blinded studyHayder Alhusseinawi, Lotte Sander, Pernille M Rosenvinge, et al.BJU International|July 28, 2023
Post-prostatectomy anastomotic stenosis: systematic review and meta-analysis of endoscopic treatmentOphélie Delchet, Mikaïl Nourredine, Adolfo González Serrano, et al.BJU International|July 25, 2023
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinomaLuca Campedel, Eva Compérat, Géraldine Cancel-Tassin, et al.BJU International|June 22, 2023
Australian surgical revision rate for benign prostatic obstructionAnika Jain, Anthony-Joe Nassour, Hadia Khannani, et al.BJU International|March 27, 2003
Differences in biopsy features between prostate cancers located in the transition and peripheral zoneH Augustin, A Erbersdobler, M Graefen, et al.BJU International|March 27, 2003
Combined treatment with vitamin E and colchicine in the early stages of Peyronie's diseaseR M Prieto Castro, M E Leva Vallejo, J C Regueiro Lopez, et al.BJU International|March 27, 2003
Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomasE Longchampt, T Lebret, V Molinie, et al.BJU International|March 5, 2003
Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?G S Merrick, W M Butler, R W Galbreath, et al.BJU International|March 5, 2003
The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?C T Brown, E O'Flynn, J Van Der Meulen, et al.BJU International|March 5, 2003
A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasiaR S KirbyPageof 888